Literature DB >> 30622297

Selective Janus kinase inhibitors come of age.

John J O'Shea1, Massimo Gadina2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30622297     DOI： 10.1038/s41584-018-0155-9

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  16 in total

Review 1.  IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-13       Impact factor: 8.667

Review 2.  [Janus kinase inhibitors : State of the art in clinical use and future perspectives].

Authors:  R Alten; M Mischkewitz; A-L Stefanski; T Dörner
Journal:  Z Rheumatol       Date:  2020-04       Impact factor: 1.372

Review 3.  Promising and Upcoming Treatments in Myositis.

Authors:  Lauren N Smith; Julie J Paik
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

Review 4.  JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy.

Authors:  Elisa Gremese; Stefano Alivernini; Barbara Tolusso; Martin P Zeidler; Gianfranco Ferraccioli
Journal:  J Leukoc Biol       Date:  2019-07-16       Impact factor: 4.962

Review 5.  Hi-JAKi-ng Synovial Fibroblasts in Inflammatory Arthritis With JAK Inhibitors.

Authors:  Blaž Burja; Tonja Mertelj; Mojca Frank-Bertoncelj
Journal:  Front Med (Lausanne)       Date:  2020-05-05

Review 6.  Transcriptional, Epigenetic and Pharmacological Control of JAK/STAT Pathway in NK Cells.

Authors:  Gianluca Scarno; Giuseppe Pietropaolo; Chiara Di Censo; Massimo Gadina; Angela Santoni; Giuseppe Sciumè
Journal:  Front Immunol       Date:  2019-10-17       Impact factor: 7.561

Review 7.  The Role of Cutaneous Type I IFNs in Autoimmune and Autoinflammatory Diseases.

Authors:  Jessica L Turnier; J Michelle Kahlenberg
Journal:  J Immunol       Date:  2020-12-01       Impact factor: 5.422

8.  Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function.

Authors:  Conor N Gruber; Jorg J A Calis; Sofija Buta; Gilad Evrony; Jerome C Martin; Skyler A Uhl; Rachel Caron; Lauren Jarchin; David Dunkin; Robert Phelps; Bryn D Webb; Jeffrey M Saland; Miriam Merad; Jordan S Orange; Emily M Mace; Brad R Rosenberg; Bruce D Gelb; Dusan Bogunovic
Journal:  Immunity       Date:  2020-08-03       Impact factor: 31.745

9.  Demonstration of In Vitro to In Vivo Translation of a TYK2 Inhibitor That Shows Cross Species Potency Differences.

Authors:  Brian S Gerstenberger; Mary Ellen Banker; James D Clark; Martin E Dowty; Andrew Fensome; Roger Gifford; Matthew C Griffor; Martin Hegen; Brett D Hollingshead; John D Knafels; Tsung H Lin; James F Smith; Felix F Vajdos
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

Review 10.  Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk.

Authors:  Suraj Rajasimhan; Omer Pamuk; James D Katz
Journal:  Drugs Aging       Date:  2020-08       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.